179 related articles for article (PubMed ID: 9434875)
1. Combined genetic polymorphism and risk for development of lung cancer.
el-Zein R; Zwischenberger JB; Wood TG; Abdel-Rahman SZ; Brekelbaum C; Au WW
Mutat Res; 1997 Nov; 381(2):189-200. PubMed ID: 9434875
[TBL] [Abstract][Full Text] [Related]
2. Interactions between genetic predisposition and environmental toxicants for development of lung cancer.
el-Zein R; Conforti-Froes N; Au WW
Environ Mol Mutagen; 1997; 30(2):196-204. PubMed ID: 9329644
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.
Anwar WA; Abdel-Rahman SZ; El-Zein RA; Mostafa HM; Au WW
Carcinogenesis; 1996 Sep; 17(9):1923-9. PubMed ID: 8824515
[TBL] [Abstract][Full Text] [Related]
4. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
6. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
7. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
8. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea.
Lee KM; Kang D; Lee SJ; Park SK; Lee KH; Choi JY; Kim SU; Choi H; Choi SH; Kim YW; Hong YC; Cho SH
Oncol Rep; 2006 Nov; 16(5):1035-9. PubMed ID: 17016589
[TBL] [Abstract][Full Text] [Related]
9. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma.
El-Zein RA; Zwischenberger JB; Abdel-Rahman SZ; Sankar AB; Au WW
Cancer Lett; 1997 Jan; 112(1):71-8. PubMed ID: 9029171
[TBL] [Abstract][Full Text] [Related]
13. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk.
Cajas-Salazar N; Sierra-Torres CH; Salama SA; Zwischenberger JB; Au WW
Int J Hyg Environ Health; 2003 Oct; 206(6):473-83. PubMed ID: 14626895
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk.
Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S
Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.
Gao Y; Zhang Q
Mutat Res; 1999 Aug; 444(2):441-9. PubMed ID: 10521684
[TBL] [Abstract][Full Text] [Related]
17. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study.
Perera FP; Mooney LA; Stampfer M; Phillips DH; Bell DA; Rundle A; Cho S; Tsai WY; Ma J; Blackwood A; Tang D;
Carcinogenesis; 2002 Oct; 23(10):1641-6. PubMed ID: 12376472
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.
González MV; Alvarez V; Pello MF; Menéndez MJ; Suárez C; Coto E
J Clin Pathol; 1998 Apr; 51(4):294-8. PubMed ID: 9659241
[TBL] [Abstract][Full Text] [Related]
20. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
